Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL18691333 | 0.84 | LMNA (0.56) | LMNAALDH1A1THRBOR51E2SLC22A6 | |
| SCHEMBL9333811 | 0.81 | — | — | |
| SCHEMBL12871589 | 0.81 | — | — | |
| Glycerin SCHEMBL7795652 | 0.81 | LMNA (0.53) | LMNAALDH1A1THRBOR51E2SLC22A6 | |
| SCHEMBL9333825 | 0.81 | — | — | |
| Glycerin SCHEMBL28619371 | 0.80 | LMNA (0.60) | LMNAALDH1A1THRBOR51E2SLC22A6 | |
| Glycerin SCHEMBL9069210 | 0.80 | LMNA (0.60) | LMNAALDH1A1THRBOR51E2SLC22A6 | |
| Glycerin SCHEMBL7030045 | 0.79 | LMNA (0.69) | LMNAALDH1A1THRBOR51E2SLC22A6 | |
| Glycerin SCHEMBL30929982 | 0.79 | LMNA (0.69) | LMNAALDH1A1THRBOR51E2SLC22A6 | |
| Glycerin SCHEMBL28563108 | 0.79 | LMNA (0.69) | LMNAALDH1A1THRBOR51E2SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108435171-A | The preparation method and a kind of method of selective catalytic oxidation glycerine DHA of a kind of bimetallic Pt-Bi catalyst | 岭南师范学院 | 2018-08-24 | — | — | CN | claimed |
| CN-108435171-A | The preparation method and a kind of method of selective catalytic oxidation glycerine DHA of a kind of bimetallic Pt-Bi catalyst | 岭南师范学院 | 2018-08-24 | — | — | CN | disclosed |
| EP-2943457-B1 | PRODUCTION OF METHACRYLIC ACID | SHELL INT RESEARCH (NL) | 2018-03-28 | — | — | EP | disclosed |
| EP-2943459-B1 | PRODUCTION OF ACRYLIC ACID | SHELL INT RESEARCH (NL) | 2018-03-28 | — | — | EP | disclosed |
| US-20130202724-A1 | SOYBEAN EXTRACTS FOR THE TREATMENT OF HEPATIC DISORDERS | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) | 2013-08-08 | — | — | US | disclosed |
| EP-2600880-A2 | SOYBEAN EXTRACTS FOR THE TREATMENT OF HEPATIC DISORDERS | Hadasit Medical Research Services And Development (IL) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012017435-A2 | SOYBEAN EXTRACTS FOR THE TREATMENT OF HEPATIC DISORDERS | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) | 2012-02-09 | — | — | WO | disclosed |
| US-7906554-B2 | Combination chemotherapy compositions and methods | NOVOGEN RESEARCH PTY LTD (AU) | 2011-03-15 | — | — | US | disclosed |
| US-7714151-B2 | Aminated isoflavonoid derivatives and uses thereof | NOVOGEN RESEARCH PTY LTD (AU) | 2010-05-11 | — | — | US | disclosed |
| US-7605135-B2 | Severe Acute Respiratory Syndrome (SARS); extracted and purified from the Chinese medicinal plant Scutellaria baicalensis Georgi | THE UNIVERSITY OF HONG KONG (CN) | 2009-10-20 | — | — | US | disclosed |
| EP-1056463-A4 | PLANT EXTRACTS AND ANTI-CANCER MODALITIES INVOLVING THE SAME | NOVOGEN RES PTY LTD (AU) | 2002-11-05 | — | — | EP | disclosed |
| WO-2002074307-A1 | TREATMENT OF RESTENOSIS | NOVOGEN RESEARCH PTY LTD (AU) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002070502-A1 | DIMERIC ISOFLAVONES | NOVOGEN RESEARCH PTY LTD (AU) | 2002-09-12 | — | — | WO | disclosed |
| WO-2002055072-A1 | REGULATION OF LIPIDS AND/OR BONE DENSITY AND COMPOSITIONS THEREFOR | NOVOGEN RESEARCH PTY LTD (AU) | 2002-07-18 | — | — | WO | disclosed |
| EP-1173165-A1 | CARDIOVASCULAR AND BONE TREATMENT USING ISOFLAVONES | Novogen Research Pty. Ltd. (AU) | 2002-01-23 | — | — | EP | disclosed |
| EP-1056463-A1 | PLANT EXTRACTS AND ANTI-CANCER MODALITIES INVOLVING THE SAME | Novogen Research Pty. Ltd. (AU) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000064438-A1 | CARDIOVASCULAR AND BONE TREATMENT USING ISOFLAVONES | NOVOGEN RESEARCH PTY LTD (AU) | 2000-11-02 | — | — | WO | disclosed |
| US-6004558-A | Methods for treating cancer with legume plant extracts | NOVOGEN, INC. (US) | 1999-12-21 | — | — | US | disclosed |
| WO-1999043335-A1 | PLANT EXTRACTS AND ANTI-CANCER MODALITIES INVOLVING THE SAME | NOVOGEN RESEARCH PTY. LTD. (AU) | 1999-09-02 | — | — | WO | disclosed |
| US-4313008-A | FROM A CHLORODEOXY-D-SACCHARIDE | TATE & LYLE LTD. (GB) | 1982-01-26 | — | — | US | disclosed |